QQ客服 官方微博 反馈留言

	Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway
	Wang H.-Y.; Zhang Y.; Zhou Y.; Lu Y.-Y.; Wang W.-F.; Xin M.; Guo X.-L.
刊名	Biomedicine and Pharmacotherapy
	2016
卷号	83页码:349-361
关键词	Cell cycle Cell proliferation and apoptosis Drug resistance reversal Oral epidermoid carcinoma PTEN/PI3K/AKT Rosiglitazone Vincristine
DOI	10.1016/j.biopha.2016.06.047
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4712978
专题	山东大学
作者单位	Department of Pharmacology, Key Laboratory of Chemical Biology , School of Pharmaceutical Sciences, Shandong Unive
推荐引用方式 GB/T 7714	Wang H.-Y.,Zhang Y.,Zhou Y.,et al. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway[J]. Biomedicine and Pharmacotherapy,2016,83:349-361.
APA	Wang H.-Y..,Zhang Y..,Zhou Y..,Lu Y.-Y..,Wang W.-F..,...&Guo X.-L..(2016).Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway.Biomedicine and Pharmacotherapy,83,349-361.
MLA	Wang H.-Y.,et al."Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway".Biomedicine and Pharmacotherapy 83(2016):349-361.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。